- Home
- CRVS vs RIV Comparison
CRVS vs RIV Comparison
Compare CRVS & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- RIV
- Stock Information
- Founded
- CRVS 2014
- RIV 2015
- Country
- CRVS United States
- RIV United States
- Employees
- CRVS N/A
- RIV N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- RIV Finance Companies
- Sector
- CRVS Health Care
- RIV Finance
- Exchange
- CRVS Nasdaq
- RIV Nasdaq
- Market Cap
- CRVS 305.4M
- RIV 258.1M
- IPO Year
- CRVS 2016
- RIV N/A
- Fundamental
- Price
- CRVS $4.10
- RIV $12.29
- Analyst Decision
- CRVS Strong Buy
- RIV
- Analyst Count
- CRVS 4
- RIV 0
- Target Price
- CRVS $15.00
- RIV N/A
- AVG Volume (30 Days)
- CRVS 445.0K
- RIV 87.6K
- Earning Date
- CRVS 08-12-2025
- RIV 01-01-0001
- Dividend Yield
- CRVS N/A
- RIV 12.85%
- EPS Growth
- CRVS N/A
- RIV N/A
- EPS
- CRVS N/A
- RIV N/A
- Revenue
- CRVS N/A
- RIV N/A
- Revenue This Year
- CRVS N/A
- RIV N/A
- Revenue Next Year
- CRVS N/A
- RIV N/A
- P/E Ratio
- CRVS N/A
- RIV N/A
- Revenue Growth
- CRVS N/A
- RIV N/A
- 52 Week Low
- CRVS $2.47
- RIV $9.63
- 52 Week High
- CRVS $10.00
- RIV $12.43
- Technical
- Relative Strength Index (RSI)
- CRVS 44.93
- RIV 52.31
- Support Level
- CRVS $4.58
- RIV $12.18
- Resistance Level
- CRVS $4.98
- RIV $12.50
- Average True Range (ATR)
- CRVS 0.23
- RIV 0.16
- MACD
- CRVS -0.04
- RIV -0.01
- Stochastic Oscillator
- CRVS 13.79
- RIV 51.16
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.